There is much evidence to support the critical function of the PI3K/Akt/mTOR signaling pathway in cancer proliferation, tumor genesis and metastasis (37,38), and numerous studies have demonstrated that PI3K/Akt/mTOR activity is increased in a variety of tumor cell lines (39–42), including leukemia (43). This evidence concerns the gene AKT1 and leukemia.